Expression of human cytotoxic T-lymphocyte antigen 4 (hCTLA4) fused with Hepatitis B surface antigen (HBsAg) using Pichia pastoris

Enzyme and Microbial Technology

Volumn 39, Issue 3, 2006, Pages 481-485

  Lee, Kyoung Hoon ^a   Hong, Hye Jin ^a   Lim, Sang Min ^a   Cheon, Su Hwan ^a   Kim, Dong Il ^a  

^a Inha University   (South Korea)

Author keywords

Hepatitis B surface antigen; Human cytotoxic T lymphocyte antigen 4; Pichia pastoris

Indexed keywords

BIOASSAY; CELLS; CYTOLOGY; DISEASES; PROTEINS; TOXICITY;

HBSAG PARTICLES; HEPATITIS B SURFACE ANTIGEN; HUMAN CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; PICHIA PASTORIS;

ANTIGENS;

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEPATITIS B ANTIGEN; HYBRID PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL FUSION; NONHUMAN; PICHIA PASTORIS; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

PICHIA PASTORIS;

EID: 33646814964     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2005.11.030     Document Type: Article

References (18)

1. David E., and Herb S. Immunological disorders. Text Book Med 4 (2000) 79-104
2. Steven M.H., and Vizi E.S. Immunomodulation. Curr Opin Pharmacol 2 (2002) 425-427
3. Thompson C.B., and Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity 7 (1997) 445-450
4. Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., and Lorsbach R.B. Sharpe AH. CTLA-4 and T cell activation. Curr Opin Immunol 11 (1999) 294-300
5. Dong C., Juedes A.E., Temann U.A., Shresta S., James P.A., Nancy H.R., et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409 (2001) 97-101
6. Mets D.P., Farber D.L., Taylor T., and Bottomly K. Differential role of CTLA-4 in regulation of resting memory versus native CD4 T cell activation. J Immunol 161 (1998) 5855-5861
7. Jeanne G.D., and Laurence A.T. New biologic immunosuppressive agents in transplantation. Curr Opin Nephrol 3 (1999) 596-601
8. Lenschow D.J., Zeng Y., Thistlethwaite J.R., Montag A., Brady W., Gibson M.G., et al. Long-term survival of xenogenic pancreatic islet grafts induced by CTLA4Ig. Science 257 (1992) 789
9. Watanabe T., Miyatake T., Kumamoto H., Mafune N., Kubota S., Okamoto H., et al. Adenovirus-mediated CTLA4 immunoglobulin G gene therapy in cardiac xenotransplantation. Transplant Proc 36 (2004) 2478-2479
10. Robert L.G., and Lutz G. Virus-like particles as vaccines and vessels for the delivery of small molecules. Curr Opin Biotechnol 15 (2004) 513-517
11. Sedlik C., Saron M.F., Sarraseca J., Casal I., and Leclerc C. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc Natl Acad Sci USA 94 (1997) 7503-7508
12. Sedlik C., Sarraseca J., Rueda P., Leclerc C., and Casal I. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid parvovirus particles. J Gen Virol 76 (1995) 2361-2368
13. Kratza P.A., Bottcher B., and Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 96 (1999) 1915-1920
14. Hardy E., Martinez E., Diago D., Diaz R., Gonzalez D., and Herrera L. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoirs. J Biotechnol 77 (2000) 157-167
15. Vijay C., Cregg J.M., and Meagher M.M. Recombinant protein production in an alcohol oxidase-defective strain of Pichia pastoris in fedbatch fermentations. Enzyme Microb Technol 21 (1997) 277-283
16. Hui J., Li G., Kong Y., and Wang Y. Expression and characterization of chimeric hepatitis B surface antigen particles carrying preS epitopes. J Biotechnol 72 (1999) 49-59
17. Yamada T., Iwasaki Y., Tada H., Iwabuki H., Chuah M., Thierry V., Fukuda H., Kondo A., Ueda M., Seno M., Tanizawa K., and Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 21 (2003) 885-890
18. Rob N., and Roy P. Virus-like particles as immunogens. Trends Microbiol 11 (2003) 438-444